Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

December 1, 2025

Conditions
Oesophageal CancerQuality of LifeBacterial Overgrowth
Interventions
DIAGNOSTIC_TEST

Breath test

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of breath.

DIAGNOSTIC_TEST

Saliva sample

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of saliva.

DIAGNOSTIC_TEST

Blood sample

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of blood.

DIAGNOSTIC_TEST

Urine sample

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of urine.

DIAGNOSTIC_TEST

Stool sample

Participants will attend an outpatient clinic, fasted for at least 4 hours for collection of stool.

DIAGNOSTIC_TEST

Health-related Quality of life questionnaires

Participants will attend an outpatient clinic and complete validated healthy-related quality-of-life questionnaires.

Trial Locations (3)

Unknown

Barking, Havering and Redbridge University Hospitals NHS Trust, London

Imperial College Healthcare NHS Trust, London

West Hertfordshire NHS Teaching Hospitals, London

All Listed Sponsors
collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

West Hertfordshire Teaching Hospitals NHS Trust

UNKNOWN

collaborator

Barking, Havering and Redbridge University Hospitals NHS Trust

OTHER

lead

Imperial College London

OTHER